Tag Archives: startups

Explore the RESI London 2025 Program Guide 

25 Nov

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

DF-News-09142022The official program guide for RESI London 2025 is now available! Redefining Every Stage of Investment (RESI) is designed to connect life science and healthcare innovators with a global network of investors across diverse funding strategies, from Seed through Series B and beyond.

This guide provides a complete overview of what to expect throughout the conference, detailing the content and layout for our in-person event on December 4th. Inside, you’ll find the full agenda, speaker bios, panel descriptions, and essential information to help you navigate your RESI experience. Whether you’re participating in investor meetings, the Innovator’s Pitch Challenge, workshops, or ad hoc networking, this guide is your resource to stay organized and maximize your time at RESI London.

Access the full guide here:

Register for RESI London

Tags: , , , , , , ,

RESI 2026 Series: Connecting Life Science Innovators with Capital and Partners 

25 Nov

By Sougato Das, President and COO, LSN

Sougato-Das

The RESI 2026 Series continues Life Science Nation’s commitment to providing consistent, high-quality partnering opportunities for life science and healthcare innovators. Designed to connect startups with investors and strategic partners that align by sector, indication, and stage of development, each RESI conference offers a structured environment for founders navigating an increasingly competitive fundraising landscape.

Throughout the 2026 Series, attendees will find a familiar mix of investor panels, expert-led workshops, the Innovator’s Pitch Challenge, and a partnering system built to support targeted outreach and productive meetings. These elements work together to help companies strengthen their messaging, expand their networks, and identify capital sources that are the best fit for their technologies.

As scientific progress accelerates and capital deployment becomes more selective, the RESI 2026 Series serves as a reliable forum for global stakeholders to exchange insights, source opportunities, and build lasting relationships across the life science ecosystem.

Find registration information at RESIConference.com. If you are interested in RESI sponsorship, please contact us.

Tags: , , , , , , , , , , , , , , , , , , ,

RESI London Innovator’s Pitch Challenge Finalists 

18 Nov

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

The Innovator’s Pitch Challenge showcases early-stage companies developing breakthrough technologies across key sectors of life sciences.

The Innovator’s Pitch Challenge (IPC) returns to RESI London with a full lineup of pioneering startups presenting across multiple themed sessions. Each finalist will pitch to panels of relevant investors and industry leaders, gaining practical feedback and creating valuable connections with partners actively seeking new technologies. The IPC provides fundraising companies with a platform to elevate their visibility and engage with a global network of investors and strategics.

If you are attending RESI London, make time to see these pitches and meet the founders throughout the day. Delegates participating in partnering can also schedule one-on-one meetings with the finalists. Full event and registration details are available at resiconference.com/resi-london.

Meet the RESI London Innovator’s Pitch Challenge Finalists

Session 1 | 9:00 – 10:00 AM | Therapeutics

Session 2 | 10:00 – 11:00 AM | Diagnostics Tools & Platforms

Session 3 | 11:00 AM – 12:00 PM | Therapeutics

Session 4 | 1:00 – 2:00 PM | Therapeutics & Medical Devices

Session 5 | 2:00 – 3:00 PM | Therapeutics

Session 6 | 3:00 – 4:00 PM | Medical Devices

Session 7 | 4:00 – 5:00 PM | R&D and Enabling Technologies
Register for RESI London

Tags: , , , , , , , , , , , ,

Discover Early-Stage Life Science Opportunities at London Bio-Innovation Week

18 Nov

By Greg Mannix, VP, EMEA Business Development, LSN

Educational sessions, networking, and investor partnering, December 2–5, 2025 

London Bio-Innovation Week brings together the global life science community for a series of premier events focused on early-stage innovation, taking place December 2–5, 2025. The week offers a unique combination of educational programming, networking opportunities, and investor partnering across multiple sectors of the life sciences. 

Participating events include RESI London by Life Science Nation, Genesis Conference by One Nucleus, the SLAS–ELRIG Meet-up, Advanced Therapies Integrates by LSI, and several free educational programs. Together, these events create an ecosystem where scientists, entrepreneurs, investors, and industry dealmakers can connect and collaborate. 

Opportunities at London Bio-Innovation Week include: 

  • Scientists engage with those commercializing innovations. 
  • Investors and industry dealmakers are discovering the next breakthroughs. 
  • Early-stage investors meet entrepreneurs seeking capital. 
  • Life science dealmakers are gaining early access to cutting-edge technologies. 
  • Building meaningful connections across the life science ecosystem. 

Join us for our upcoming webinar, that will provide an overview of London Bio-Innovation Week, highlighting how the events can help advance your company, discover investment opportunities, and connect with key partners. 

Webinar Speakers: 

  • Sougato Das, President & COO, Life Science Nation 
  • Tony Jones, Chief Executive Officer, One Nucleus 
  • Vicki Loise, Chief Executive Officer, SLAS (Society for Laboratory Automation and Screening) 
  • Sanj Kumar, Chief Executive Officer, ELRIG 

Webinar Details: 

  • Date & Time: November 20, 2025, 9:00 AM Eastern Time (US & Canada) 

Register RESI London now to explore all the ways London Bio-Innovation Week can support your early-stage life science goals and connect you with the right partners. 

Register for RESI London

Tags: , , , , ,

Navigating JPM Week: A Guide to RESI’s 2026 Event Lineup 

18 Nov

By Max Braht, Director of Business Development, LSN

Max-Braht-Headshot

As the life science world converges on San Francisco for J.P. Morgan Healthcare Week in January 2026, the RESI Conference plays a central role, and its website’s dedicated “JPM Week Events” page is an essential resource for attendees and stakeholders alike. Here’s a breakdown of what the site offers and why it’s such a valuable hub. 

What Is the JPM Week Events Page? 

The RESI “JPM Week Events” page is essentially a curated calendar and guide, maintained by Life Science Nation. It compiles an exhaustive list of life science–oriented events happening in parallel with JPM Healthcare Week, from early morning breakfasts to high-level receptions and symposiums.  

It’s not just a list; it’s a strategic tool for entrepreneurs, investors, and corporates to plan how to maximize their time during one of the most frenetic weeks in biotech and healthcare investments. 

What’s on the Agenda: Highlights from the 2026 Schedule 

Here is some standout events listed for January 2026 on RESI’s page: 

January 10–11: 

  • San Francisco CEO | Longwood Healthcare Leaders Forum — A full-day leadership forum at the Four Seasons.  
  • 9th Annual Neuroscience Innovation Forum — Focused on business development, licensing, and investment, held at the Marines’ Memorial Club.  
  • PwC Executive Women’s Event — A networking event aimed at women leaders in healthcare.  
  • Yafo Capital ACCESS ASIA BD Forum — A cross-border business development forum in San Francisco.  

January 12: 

  • RESI JPM 2026 Conference at the San Francisco Marriott Marquis.  
  • AcuityMD Sunrise Partnering Breakfast — An early morning session for high-value partnering.  
  • AdvaMed Member Meeting Space & Receptions — Dedicated space for AdvaMed members.  
  • Incubate & DLA Piper: Innovation at a Crossroads — A policy-focused discussion on biopharma strategy in a changing global landscape.  
  • Lifeblood & Goodwin MedTech CEO-only Forum — A specialized gathering for medtech CEOs.  
  • MassBio Meeting Space & Receptions — Hosted by MassBio at the Parc 55 Hotel.  
  • QNova LifeSciences 12th Annual Partnering Forum — A major partnering event in the Hilton Union Square.  
  • PMI Biotech Reception — A dinner reception at InterContinental Mark Hopkins.  
  • Aquillius Pitch Showcase — A pitching event for life sciences companies. 
  • Biovia Event: Clusters of Excellence — A forum on European life science clusters and global success.  
  • T2Bmeet @ JPM — A streamlined meeting event to facilitate business development and partnering.  
  • Scale Biosciences JPM Happy Hour — Evening social for dealmakers.  
  • STAT @ JPM26 Live — A live event by STAT News.  
  • Reed Smith Reception — At the Museum of the African Diaspora. 
  • Deloitte Reception — A networking evening hosted by Deloitte.  

January 13: 

  • Continuation of RESI JPM 2026.  
  • Fierce JPM Week — A track that runs throughout JPM Week, focused on dealmaking and thought leadership. 
  • Biocom California Events — Receptions, meeting space, and more at Omni San Francisco. 
  • KoreaBIO / BioCentury / Sidley Austin IR Forum — Global investor relations forum.  
  • LaunchBio & Inspira Innovators Social Hour — A more informal social event for early-stage founders.  
  • Katten’s Diptyque Client Reception — A luxury experience for select invitees. 
  • Dartmouth Offsite — Hosted at the Beacon Grand Hotel.  
  • Bits in Bio Reception — For emerging biotech companies and leaders.  

January 14–15: 

  • Multiple networking breakfasts, partnering forums, and receptions.  
  • HCPEA Women’s Mentor/Mentee Networking Breakfast on January 14. 
  • 2026 Stanford Alumni in Healthcare Networking Mixer — A Stanford alumni focused event. 
  • CTIP Innovator Showcase (Jan 15) — For pediatric technology innovators. 
  • MBC BioLabs: Meet the Founders — Founders’ networking at a biotech incubator.  
  • Toplink Conference @ JPM — A full-day conference on tech + life science.  
  • Swissnex Networking Event — International networking through the Swissnex channel.  
  • And more receptions, including PCI Pharma Services, California Israel Chamber of Commerce Israel Lounge, and Destination Medical Center Discovery Exchange.  

Why This Page Matters 

  1. Comprehensive Planning Tool: For anyone attending JPM Week — whether founders, investors, BD execs, or scientists — having a central, curated list of relevant life science events is invaluable. Rather than navigating a sea of scattered invitations, the RESI page brings together a clean, structured schedule. 
  1. Partnership Optimization: Many of the events listed are tailored for dealmaking — breakfasts, partnering forums, and pitch showcases. This makes it easier for startups to schedule and maximize high-impact interactions. 
  1. Community Spotlight: The page isn’t only about formal conferences; it also highlights social events, networking mixers, and sector-specific receptions (e.g., women in healthcare, neuroscience, medtech). This helps attendees connect on both professional and personal levels. 

The RESI “JPM Week Events” page is more than just a listing: it’s a strategic roadmap for navigating one of the busiest and most important weeks in healthcare investing. By consolidating diverse events, boardroom policy talks to rooftop cocktail receptions; it empowers life science professionals to plan smarter, connect deeper, and maximize their time. 

For anyone participating in RESI JPM 2026, bookmarking this page is one of the first steps to making the most of the week. 

Register for RESI JPM >>

Tags: , , , , , , , , , , , , , , , , , , ,

Early-Stage Partnerships with Mosaic Biosciences at RESI London 

18 Nov

By Matt Stanton, VP Sales US West, Central and South America, LSN

Mara Sprouce, Director of Commercial Operations at Mosaic Biosciences, shares how their team of drug hunters and problem solvers support early-stage biotech partners from concept to candidate. In this interview, Mara discusses Mosaic’s collaborative approach to innovation, how their platform adapts to diverse modalities and target classes, and what sets them apart from a traditional CRO. She also highlights the types of partners they’re eager to meet at RESI London and what attendees can look forward to when connecting with the Mosaic team on-site.

Register for RESI London

Tags: , , , , ,

From Lab to Market: Why Life Science Companies Are Drawn to Singapore 

12 Nov

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

LSN is proud to announce our partnership with Enterprise SG for RESI JPM 2026, to foster meaningful conversations on global life science innovation, investment and cross-border collaboration. Learn how Singapore is a dynamic launchpad for innovation and home to cutting-edge startups ready to collaborate on your next breakthrough. Join us at our upcoming panel on January 12 to find out more! 

As global healthcare challenges intensify, innovative biomedical technologies from Asia are stepping up to drive change, translating life science research into real-world solutions. Increasingly, investors, corporates, startups, and healthcare systems around the world are seeing the urgency in bridging the East and West to improve healthcare outcomes and deliver value-based care.

Singapore, located at the heart of Asia, is a dynamic hub for biomedical innovation, driven by a strong network of global investors, researchers, mentors, and innovators. With decades of sustained government investments and a robust talent pipeline from world-class universities and research institutes, it is home to over 500 biomedical and medtech companies. The ecosystem has attracted venture capitalists and venture builders like MPM BioImpact, Polaris Partners, and Flagship Pioneering, as well as global pharma leaders such as Pfizer, Roche, and Johnson & Johnson. These players work closely with government agencies, like Enterprise Singapore, that drive startup development, provide patient funding, expertise, infrastructure, and networks crucial for producing globally competitive solutions.

Singapore’s strategic position as a bridge between Asian and global markets enables it to play an outsized role in driving biomedical advancements. This works both ways, as a gateway for global companies to access the growing opportunities in Asia, and as a springboard for regional companies to expand worldwide. For example, through partnerships with healthcare organisations like Cedars-Sinai and Mayo Clinic in the US, Enterprise Singapore supports Singapore startups to test and scale their solutions in overseas markets, facilitating a bi-directional flow of innovation to improve healthcare for communities.

Join Enterprise Singapore at the ‘Asia Cross Border Investments Panel’ to explore how cross-border capital, talent, and technologies are converging to drive breakthroughs in precision medicine, innovative therapies, and next-generation diagnostics. The panel will take place on January 12, 2026, from 11:00 am to 12:00 pm at RESI JPM by LSN, held at the Marriott Marquis, San Francisco. Learn from prominent industry leaders how transcontinental partnerships, including those with Singapore, are shaping the future of healthcare innovation – from discovery to global commercialisation.

To join the conversation, please contact Claire Jeong, VP of Investor Research, Asia BD, at c.jeong@lifesciencenation.com.

Tags: , , , , , , , , , , ,

← Older Entries
Newer Entries →